Learn how pH-sensitive dye detection supports reliable ADC internalization assays and insight into cellular uptake mechanisms ...

ADC conjugation, redefined. Explore a rapid 3-hour workflow that delivers precise, controlled antibody-drug conjugates for ...

Vaxcyte recently reported further progress on its next-generation 31-valent pneumococcal conjugate vaccine VAX-31, including first dosing in the adult OPUS-2 Phase 3 trial, completion of enrollment in ...

With Enhertu and Datroway, Daiichi Sankyo has made itself a top-tier player in antibody-drug conjugates. | With Enhertu and Datroway, Daiichi Sankyo has made itself a top-tier player in antibody-drug ...

Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...

The oncology market in the United States was estimated at $81.34 billion in 2025 and is expected to reach $211.78 billion by ...

We expect strong CDMO growth in 2026, driven by geopolitical fragmentation and regional manufacturing consolidation ...

The Morgan Lewis cross-functional and cross-jurisdiction life sciences and healthcare teams were represented in San Francisco ...

Company says influence of one biologics client played through its December quarter numbers, but stressed that performance outside this programme remained stable across manufacturing and research ...

JCBio appointed for Korea; Tekon Biotech appointed for China provide access to liver and small-intestine NAM screening with 'molecules in, data out” speed and human relevance ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Annie Chou Annie Chou is a writer covering home office, cameras, and games.

Avacta Therapeutics (AIM: AVCT), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated ...